• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1300035 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-07-22 嘉和生物药业有限公司 Genor Biopharma Co Ltd Certificate Issued 2016-03-28 view
CXSL1300062 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2013-11-04 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2016-01-14 view
CXSL1500023 重组抗肿瘤坏死因子-α全人源单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-05-08 北京东方百泰生物科技有限公司 Beijing Dongfang Biotech Co Ltd Certificate Issued 2017-02-13 view